Plexision
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4424 Penn Ave Ste 202, Pittsburgh, Penns...Phone Number
(855) 753-9474Website
www.plexision.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Plexision
Plexision is a biotechnology company specializing in the development of cellular biomarkers for personalized diagnostics and drug development, particularly in solid organ transplantation and immunological disorders. Their product offerings include a range of FDA-approved blood tests that predict the risk of transplant rejection and assess cellular immunity to various viral infections, including COVID-19. The company also engages in custom R&D projects aimed at integrating biomarker targets throughout all phases of drug development. Plexision's state-of-the-art laboratory is located in Pittsburgh, PA, and is CLIA-certified.Explore more
Plexision Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Plexision your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Plexision is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Plexision recently announced quarterly report
Check if Plexision has recently received funding, and reach out quickly before it becomes old news!
Plexision, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Plexision
Product Launch: Get notified when Plexision launches new products
Click to see if Plexision had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Plexision has new funding data
Recommended Actions
Reach out to Masked Content who joined Plexision as Masked Content
Find more new buyers
Compare Similar Companies to Plexision
Compare insights from companies similar to Plexision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Plexision is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Plexision is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Plexision.
Plexision financials insights
Gather financial insights about Plexision, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$41K
2025
Other Financing Round
$365K
Plexision Tech Stack
Most Recent Scoops
Funding
Funding
Facilities Relocation / Expansion
Facilities Management
Funding
Plexision has received an SBA PPP loan in the amount of $41,760 from PNC Bank resulting in the retention of 6 jobs.
Funding
Funding
Plexision News & Media
Plexision launches personalized transplant diagnostic testing in India
PITTSBURGH--(BUSINESS WIRE)-- #ISOT--Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India. This laboratory will offer a comprehensive range of tests for transplant patients. These tests include the company’s exclusive personalized transplant diagnostic tests to predict rejection and viral infections, as well as drug level monitoring, pharmacogenomics, and genetic testing. The company’s products were shPlexision completes development of PlexAPR™, a rapid blood test to predict transplant rejection
PITTSBURGH--(BUSINESS WIRE)-- #healthcare--Plexision, a biotechnology company, which provides personalized diagnostic testing services for organ transplant patients has completed development of a six-hour blood test to predict organ transplant rejection - PlexAPR™. When combined with other clinical and laboratory information, rapid rejection-risk assessment can allow caregivers to intervene early, while arranging confirmatory biopsies, or during lifelong surveillance of organ health. To learn moPlexision Receives Laboratory Accreditation by the College of American Pathologists
PITTSBURGH--(BUSINESS WIRE)--Plexision receives Laboratory Accreditation by College of American PathologistsPlexision Awarded Competitive Grant from the National Science Foundation to Develop its Novel COVID-19 Immunity Test
PITTSBURGH--(BUSINESS WIRE)-- #cellimmunity--Plexision, (www.plexision.com) a biotech company specializing in cell-based technologies, has been awarded a National Science Foundation (NSF) Phase 1 Small Business Innovation Research grant. This funding will be used to develop a widely available version of Plexision’s novel immunity test for COVID-19 infection. Current tests assess protective immunity by measuring antibodies, which develop after infection. Plexision’s blood test measures cell-media
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Plexision
Sign Up For FreeTo access detailed company insights
Plexision is a biotechnology company specializing in the development of cellular biomarkers for personalized diagnostics and drug development, particularly in solid organ transplantation and immunological disorders. Their product offerings include a range of FDA-approved blood tests that predict the risk of transplant rejection and assess cellular... Read More
